Literature DB >> 3708873

Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis.

A W Goolden, J S Stewart.   

Abstract

An analysis has been made of the results of treatment in a series of 261 consecutive patients given graded low dose radioactive iodine therapy for thyrotoxicosis. Of these patients, 140 (54%) became euthyroid after a single dose of 131I and a further 50 (19%) achieved a remission after supplementary treatment with an antithyroid drug; 45 patients (17%) required further treatment with 131I which was invariably curative. The incidence of hypothyroidism was 10% at 1 year. The subsequent incidence of hypothyroidism in the whole group was 27% at 5 years, 40% at 10 years and 53% at 15 years. Patients continued to become hypothyroid at a constant rate of 3% per year. The incidence of early hypothyroidism can be reduced to some extent by using low doses of 131I and by relating the dose to the size of the gland. Late hypothyroidism on the other hand is due to latent nuclear damage and is inherent in the method of treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708873     DOI: 10.1111/j.1365-2265.1986.tb00765.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.

Authors:  K Sugino; T Mimura; O Ozaki; H Iwasaki; N Wada; A Matsumoto; K Ito
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

2.  A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism.

Authors:  C Marcocci; D Gianchecchi; I Masini; F Golia; C Ceccarelli; E Bracci; G F Fenzi; A Pinchera
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

3.  Current and emerging treatment options for Graves' hyperthyroidism.

Authors:  Prakash Abraham; Shamasunder Acharya
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

4.  Long-term results of two schedules of radioiodine treatment for toxic multinodular goitre.

Authors:  D A Huysmans; A R Hermus; F H Corstens; P W Kloppenborg
Journal:  Eur J Nucl Med       Date:  1993-11

5.  Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease.

Authors:  U F Willemsen; P Knesewitsch; T Kreisig; C R Pickardt; C M Kirsch
Journal:  Eur J Nucl Med       Date:  1993-11

6.  A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism.

Authors:  Suhail AR Doi; Issa Loutfi; Kamal AS Al-Shoumer
Journal:  BMC Nucl Med       Date:  2001

Review 7.  Pediatric Graves' disease: management in the post-propylthiouracil Era.

Authors:  Scott A Rivkees
Journal:  Int J Pediatr Endocrinol       Date:  2014-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.